Literature DB >> 11299815

Histological grading in gastric cancer by Goseki classification: correlation with histopathological subtypes and prognosis.

S Mönig1, S E Baldus, P H Collet, T K Zirbes, E Bollschweiler, J Thiele, H P Dienes, A H Hölscher.   

Abstract

BACKGROUND: Many different classification systems have been proposed for the histological classification and grading of gastric cancer. In 1992 Goseki described a novel classification system for gastric cancer based on tubular differentiation and mucus in the cytoplasm. The aim of the study was to compare the Goseki classification with the currently used classification systems and to define the prognostic significance of the Goseki classification system. PATIENTS AND METHODS: The present study analyzed material from 200 gastric carcinoma patients who underwent gastrectomy with curative intention. All specimens were categorized to UICC-classification, WHO-classification, Laurén classification, tumor differentiation and Goseki classification. The median follow-up for surviving patients was 3.75 years (range, 0.14-11.52).
RESULTS: According to the Goseki classification 32% of patients were classified as group I, 11.5% as group II, 9.5% as group III and 48% as group IV. The Goseki classification was found to correlate with the WHO and Lauren classification as well as with conventional grading. Goseki classification as well as tumor differentiation, Lauren and WHO classification did not have prognostic value for survival. Only the UICC system presented as an independent prognostic factor in multivariate analysis (p < 0.000001).
CONCLUSION: In our series Goseki classification correlated with conventional classification systems, but not with survival.

Entities:  

Mesh:

Year:  2001        PMID: 11299815

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  6 in total

1.  Prognostic significance of serum alkaline phosphatase and lactate dehydrogenase levels in patients with unresectable advanced gastric cancer.

Authors:  Tsutomu Namikawa; Nobuko Ishida; Sachi Tsuda; Kazune Fujisawa; Eri Munekage; Jun Iwabu; Masaya Munekage; Sunao Uemura; Shigehiro Tsujii; Takahiko Tamura; Tomoaki Yatabe; Hiromichi Maeda; Hiroyuki Kitagawa; Michiya Kobayashi; Kazuhiro Hanazaki
Journal:  Gastric Cancer       Date:  2018-11-11       Impact factor: 7.370

2.  Neutrophil-to-lymphocyte ratio and C-reactive protein-to-albumin ratio as prognostic factors for unresectable advanced or recurrent gastric cancer.

Authors:  Tsutomu Namikawa; Shigeto Shimizu; Keiichiro Yokota; Nobuhisa Tanioka; Masaya Munekage; Sunao Uemura; Hiromichi Maeda; Hiroyuki Kitagawa; Michiya Kobayashi; Kazuhiro Hanazaki
Journal:  Langenbecks Arch Surg       Date:  2021-10-15       Impact factor: 3.445

Review 3.  Pathohistological classification systems in gastric cancer: diagnostic relevance and prognostic value.

Authors:  Felix Berlth; Elfriede Bollschweiler; Uta Drebber; Arnulf H Hoelscher; Stefan Moenig
Journal:  World J Gastroenterol       Date:  2014-05-21       Impact factor: 5.742

4.  Histological grading in gastric cancer by Ming classification: correlation with histopathological subtypes, metastasis, and prognosis.

Authors:  Thomas Luebke; Stephan E Baldus; Guido Grass; Elfriede Bollschweiler; Jürgen Thiele; Hans-Peter Dienes; Arnulf H Hoelscher; Stefan P Moenig
Journal:  World J Surg       Date:  2005-11       Impact factor: 3.282

5.  Superiority of Tumor Location-Modified Lauren Classification System for Gastric Cancer: A Multi-Institutional Validation Analysis.

Authors:  Lin-Yong Zhao; Jun-Jiang Wang; Yong-Liang Zhao; Xin-Zu Chen; Kun Yang; Xiao-Long Chen; Wei-Han Zhang; Kai Liu; Xiao-Hai Song; Jia-Bin Zheng; Zong-Guang Zhou; Pei-Wu Yu; Yong Li; Jian-Kun Hu
Journal:  Ann Surg Oncol       Date:  2018-07-26       Impact factor: 5.344

6.  SFRP4 drives invasion in gastric cancer and is an early predictor of recurrence.

Authors:  Rita A Busuttil; Joshy George; Colin M House; Stephen Lade; Catherine Mitchell; Natasha S Di Costanzo; Sharon Pattison; Yu-Kuan Huang; Patrick Tan; Jae-Ho Cheong; Sun Young Rha; Alex Boussioutas
Journal:  Gastric Cancer       Date:  2020-12-04       Impact factor: 7.370

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.